S Niezen et al, 2021. Coffee consumption is associated with lower liver stiffness: a nationally representative study, Clinical Gastroenterology and Hepatology, in Press.
M Ebadi et al, 2021. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies, Nutrients, Volume 13 (9).
N F Lange et al, 2021. Prevention of NAFLD-associated HCC: role of lifestyle and chemoprevention, Journal of Hepatology, published online.
O J Kennedy at al, 2021. All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study, BMC Public Health, Volume 21 Article 970.
J Chhimwal et al, 2021. Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink, Clinical Nutrition, Volume 40 (1).
C Lammert et al, 2021. Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption, Dig Dis Sci, published online.
I Mikolasevic et al, Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis: controlled attenuation parameter and liver stiffness measurements, International Journal of Clinical Practice, published online.
J B Whitfield et al, 2020. Obesity, diabetes, coffee, tea, and cannabis use alter risk for alcohol related cirrhosis in 2 large cohorts of high risk drinkers, American Journal of Gastroenterology, published online.
Y Zhang et al, 2020. Habitual coffee intake and risk for non-alcoholic fatty liver disease: a two-sample Mendelian randomization study, European Journal of Nutrition, published online
X Zhang et al, 2020. Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease, Liver International, published online.
This information is intended for Healthcare professional audiences.
Please consider the environment before printing.